IL157461A0 - Use of carboxamido imidazo [1,2] pyridine deivatives in the preparation of medicaments for treating or preventing gastric ulcer - Google Patents

Use of carboxamido imidazo [1,2] pyridine deivatives in the preparation of medicaments for treating or preventing gastric ulcer

Info

Publication number: IL157461A0
Authority: IL; Israel
Prior art keywords: deivatives; carboxamido; imidazo; medicaments; pyridine
Prior art date: 2001-03-08

Application number

IL15746102A

Other languages

English (en)

Original Assignee

Astrazeneca Ab Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-08

Filing date

2002-03-05

Publication date

2004-03-28

2001-03-08 Priority claimed from SE0100798A external-priority patent/SE0100798D0/xx

2001-10-03 Priority claimed from SE0103291A external-priority patent/SE0103291D0/xx

2002-03-05 Application filed by Astrazeneca Ab Astrazeneca Ab filed Critical Astrazeneca Ab Astrazeneca Ab

2004-03-28 Publication of IL157461A0 publication Critical patent/IL157461A0/xx

Links

JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 title 2
208000007107 Stomach Ulcer Diseases 0.000 title 1
125000005518 carboxamido group Chemical group 0.000 title 1
239000003814 drug Substances 0.000 title 1
201000005917 gastric ulcer Diseases 0.000 title 1
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IL15746102A 2001-03-08 2002-03-05 Use of carboxamido imidazo [1,2] pyridine deivatives in the preparation of medicaments for treating or preventing gastric ulcer IL157461A0 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
SE0100798A SE0100798D0 (sv)	2001-03-08	2001-03-08	New use
SE0103291A SE0103291D0 (sv)	2001-10-03	2001-10-03	New use
PCT/SE2002/000375 WO2002069968A1 (en)	2001-03-08	2002-03-05	New use

Publications (1)

Publication Number	Publication Date
IL157461A0 true IL157461A0 (en)	2004-03-28

Family

ID=26655407

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL15746102A IL157461A0 (en)	2001-03-08	2002-03-05	Use of carboxamido imidazo [1,2] pyridine deivatives in the preparation of medicaments for treating or preventing gastric ulcer

Country Status (15)

Country	Link
US (2)	US20040082605A1 (cs)
EP (1)	EP1370261A2 (cs)
JP (1)	JP2004520422A (cs)
KR (1)	KR100904599B1 (cs)
CN (1)	CN1496259A (cs)
BG (1)	BG108144A (cs)
BR (1)	BR0207762A (cs)
CA (1)	CA2440100A1 (cs)
CZ (1)	CZ20032398A3 (cs)
EE (1)	EE05234B1 (cs)
IL (1)	IL157461A0 (cs)
MX (1)	MXPA03007888A (cs)
NO (1)	NO20033919L (cs)
SK (1)	SK10982003A3 (cs)
WO (1)	WO2002069968A1 (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6852739B1 (en)	1999-02-26	2005-02-08	Nitromed Inc.	Methods using proton pump inhibitors and nitric oxide donors
AU2003254282A1 (en) *	2002-08-01	2004-02-23	Nitromed, Inc.	Nitrosated proton pump inhibitors, compositions and methods of use
WO2004026867A2 (en) *	2002-09-19	2004-04-01	Schering Corporation	Imidazopyridines as cyclin dependent kinase inhibitors
KR20050072090A (ko) *	2002-09-19	2005-07-08	쉐링 코포레이션	사이클린 의존성 키나제 억제제로서의 피라졸로피리딘
BRPI0407541A (pt) *	2003-02-17	2006-02-14	Altana Pharma Ag	combinações e uso de compostos farmaceuticamente ativos selecionados
JPWO2011102460A1 (ja) *	2010-02-19	2013-06-17	学校法人関西医科大学	胃潰瘍の予防又は治療剤、経口投与薬、及び胃潰瘍の予防又は治療剤の製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AT290523B (de) *	1962-01-05	1971-06-11	Merck & Co Inc	Verfahren zur Herstellung neuer α-(3-Indolyl)-carbonsäuren
ZA81219B (en) *	1980-01-23	1982-01-27	Schering Corp	Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
EP0068378B1 (en) *	1981-06-26	1986-03-05	Schering Corporation	Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
DE3922387A1 (de) *	1989-07-07	1991-01-17	Kali Chemie Pharma Gmbh	N-benzyl-n-((1s,5s)-6,6-dimethylbicyclo/3.1.1/hept-2-ylaethoxy-aethyl)-morpholinium-salze enthaltende gastroprotektiv wirksame pharmazeutische zubereitungen
IN171746B (cs) *	1989-11-02	1992-12-26	Mcneil Ppc Inc
KR920002148A (ko) *	1990-07-03	1992-02-28	안드레아 엘. 콜비	비스테로이드계 소염제에 의해 유발된 위장 증상을 완화시키기 위한 약제 조성물 및 이를 완화시키는 방법
DK0550083T3 (da) *	1991-12-06	1999-10-11	Glaxo Group Ltd	Lægemidler til behandling af inflammatoriske tilstande eller til analgesi og indeholdende et NSAID og ranitidinbismuthcitra
HUP0001555A3 (en) *	1997-10-30	2001-01-29	Altana Pharma Ag	Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
SE9801526D0 (sv) *	1998-04-29	1998-04-29	Astra Ab	New compounds
WO2000017200A1 (en) *	1998-09-23	2000-03-30	Byk Gulden Lomberg Chemische Fabrik Gmbh	Tetrahydropyridoethers
AU3966600A (en) *	1999-04-17	2000-11-02	Byk Gulden Lomberg Chemische Fabrik Gmbh	Haloalkoxy imidazonaphthyridines

2002
- 2002-03-05 CZ CZ20032398A patent/CZ20032398A3/cs unknown
- 2002-03-05 JP JP2002569143A patent/JP2004520422A/ja active Pending
- 2002-03-05 IL IL15746102A patent/IL157461A0/xx unknown
- 2002-03-05 KR KR1020037011676A patent/KR100904599B1/ko not_active Expired - Fee Related
- 2002-03-05 CA CA002440100A patent/CA2440100A1/en not_active Abandoned
- 2002-03-05 WO PCT/SE2002/000375 patent/WO2002069968A1/en not_active Ceased
- 2002-03-05 CN CNA028061098A patent/CN1496259A/zh active Pending
- 2002-03-05 BR BR0207762-0A patent/BR0207762A/pt not_active IP Right Cessation
- 2002-03-05 MX MXPA03007888A patent/MXPA03007888A/es not_active Application Discontinuation
- 2002-03-05 SK SK1098-2003A patent/SK10982003A3/sk not_active Application Discontinuation
- 2002-03-05 EP EP02701851A patent/EP1370261A2/en not_active Withdrawn
- 2002-03-05 US US10/469,906 patent/US20040082605A1/en not_active Abandoned
- 2002-03-05 EE EEP200300434A patent/EE05234B1/xx not_active IP Right Cessation
2003
- 2003-09-01 BG BG108144A patent/BG108144A/xx unknown
- 2003-09-04 NO NO20033919A patent/NO20033919L/no not_active Application Discontinuation
2008
- 2008-08-04 US US12/185,514 patent/US20090170854A1/en not_active Abandoned

Also Published As

Publication number	Publication date
BR0207762A (pt)	2004-06-01
CN1496259A (zh)	2004-05-12
EP1370261A2 (en)	2003-12-17
EE05234B1 (et)	2009-12-15
WO2002069968A8 (en)	2003-04-17
EE200300434A (et)	2003-12-15
CZ20032398A3 (cs)	2004-02-18
JP2004520422A (ja)	2004-07-08
KR100904599B1 (ko)	2009-06-25
KR20040007461A (ko)	2004-01-24
CA2440100A1 (en)	2002-09-12
US20040082605A1 (en)	2004-04-29
BG108144A (en)	2004-09-30
US20090170854A1 (en)	2009-07-02
NO20033919D0 (no)	2003-09-04
MXPA03007888A (es)	2003-12-04
SK10982003A3 (sk)	2004-02-03
NO20033919L (no)	2003-09-04
WO2002069968A1 (en)	2002-09-12

Publication	Publication Date	Title
AU7922900A (en)	2001-05-08	Thiazole and imidazo (4,5-b) pyridine compounds and their pharmaceutical use
IL191960A (en)	2015-11-30	History of imidazo [5,1– a] pyridine and pharmaceutical preparations containing them
HUP0102556A3 (en)	2002-12-28	Benzenesulfonamide-derivatives and their use as medicaments and process for the preparation of the compounds
AU2002251546A1 (en)	2003-04-17	Pyrazolo[1,5-A]pyridines and medicines containing the same
IL160707A0 (en)	2004-08-31	1, 8-naphthyridine derivatives as antidiabetics
AU2001262723A1 (en)	2002-03-14	1,2-dihydropyridine compounds, process for preparation of the same and use thereof
IL142371A0 (en)	2002-03-10	2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
HUP0003265A3 (en)	2001-03-28	Nutritional composition for the treatment of pressure ulcers
IL147923A0 (en)	2002-08-14	3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
IL147925A0 (en)	2002-08-14	3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents
HUP9900163A3 (en)	2001-10-29	Process for the preparation of sterol-and stanol-esters, and use thereof
HUP0102585A3 (en)	2002-04-29	Thienylazolylalcoxyethanamin derivatives preparation the same and their use as medicaments
AU5089400A (en)	2000-12-28	Arthritis treatment
SI1105391T1 (en)	2005-02-28	Imidazo(1,2-a)pyridine compounds that inhibit gastric acid secretion, pharmaceutical compositions thereof, and processes for thier preparation
PL349364A1 (en)	2002-07-15	Use of pyridazino[4,5-b
PL349341A1 (en)	2002-07-15	Imidazo[4,5-c]-pyridine-4-on-derivatives
PL366858A1 (en)	2005-02-07	Use of substituted imidazo[1,2-a]-pyridine compounds as medicaments
NZ288609A (en)	1998-12-23	Substituted (4-thiopyridinyl) methylthio-benzimidazole (or 1h-imidazo-[2,3-b]-pyridine) and medicaments
AU2002243363A1 (en)	2002-07-24	Use of aziridino-compounds in the treatment of immune dysfunctions
ZA983376B (en)	1998-07-03	Process for the preparation of flupirtine maleate.
AU2001279958A1 (en)	2002-03-04	Bicyclic heteroaromatic derivatives for the treatment of immune and inflammatorydisorders
MXPA03008894A (es)	2003-12-08	Uso de compuestos de imidazo[1,2-a]-piridin-3-il-amidas e imidazo [1,2-a]-piridin-3-il-aminas sustituidas como medicamentos.
HUP0401577A3 (en)	2010-03-29	Process for the preparation of 2,4-didezoxyhexoses and 2,4,6-tridezoxyhexoses
HUP0102409A2 (hu)	2001-12-28	Pirimidin- (amino-metil) -pirimidin-származékok, előállításuk és felhasználásuk Helicobacter baktériumok ellen
AU1940800A (en)	2000-07-12	Combination therapy for the treatment of sepsis